National Graphite

NGRC · OTC

$0.0273−$0.0017 (−5.86%)TodayMarket closed · Oct 20, 9:58 AM ET

Prev close $0.029

About NGRC

National Graphite Corp. is an exploration company, which engages in the exploration of gold, silver, and related minerals. The company is headquartered in Dusseldorf, Nordrhein-Westfalen. The company went IPO on 2009-06-30. The firm is pursuing the commercial development of a drug candidate, elafin, for the treatment of postoperative inflammatory complications. Elafin is a human identic protein. The firm operates in Germany, in collaboration with clinical-stage companies that develop new biological entities or new therapeutically platforms in the treatment for various diseases, rare diseases and diseases with unmet needs. Biotech Development Corp. is the Company's subsidiary. As of February 28, 2015, the Company had not generated any revenues.

Employees: 1
Headquarters: Dusseldorf, Nordrhein-Westfalen
Listed: Jun 30, 2009
Sector: Health Care
Industry: Biotechnology

Leadership

National Graphite executives
Name	Title	Since	Age
Ulrike Dickmann	—	2014	63
Verena Becchio	—	2015	74

Similar companies

Companies in the same industry as National Graphite

BNTXBioNTech SE$91.17+2.20%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.